| 发布于: | Android | 转发：0 | 回复：0 | 喜欢：0 |
$Sorrento Therapeutics, Inc. (SRNE)$ Recently, In an analyst report shared with investors and clients on Monday, 11 June, Sorrento Therapeutics (NASDAQ:SRNE) shares have had their Buy Rating reiterated by stock analysts at H.C. Wainwright, who currently has a $40.0000 TP on c...